IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re the application of:
`
`Attorney Docket No.: 2005.86USREI6
`
`PATENT APPLICATION
`
`Howard C, Rootet al.
`
`Application No.: —14/195,435
`
`Filed:
`
`March3, 2014
`
`Confirmation No.: 9278
`
`Examiner: Unassigned
`
`Group Art Unit: 3767
`
`For: COAXIAL GUIDE CATHETER FOR INTERVENTIONAL CARDIOLOGY
`PROCEDURES
`
`REQUEST FOR CORRECTED FILING RECEIPT
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`Applicant notes the followingerrorin the official Filing Receipt mailed April 2, 2014:
`
`This application is a CON of 14/070,161 11/01/2013 PAT RE45380
`Whichis a REI of 13/359,059 01/26/2012 PAT 8292850
`
`Which is a DIV of 12/824,734 06/28/2010 PAT 8142413
`
`Whichis a DIV of 11/416,629 05/03/2006 PAT 8048032
`
`This application is a REI of 13/359,059 01/26/2012 PAT 8292850
`Whichis a DIV of 12/824,734 06/28/2010 PAT 8142413
`
`Whichis a DIV of 11/416,629 05/03/2006 PAT 8048032
`
`
`

`

`Enclosed is a photocopy of the filing receipt with the correction required marked.
`
`Applicant requests issuance of a corrected filing receipt.
`
`Application Ne. 14/195.435
`
`Resnecthully submjtted,‘“\
`<
`) eye
`{
`:
`foe pe
`:
`of
`ae
`<
`é
`z bt
`=
`7
`{
`saeees So.
`Oe
`
`Paul C. Onderick
`Repistration No. 45354
`
`Customer No. 24113
`Patterson Thuente Pedersen, PLA.
`4800 IDS Center
`80 South 8th Street
`Minneapolis, Minnesota 35402-2100
`Telephone: 612.349.5766
`
`Please grant any extension of tine necessaryfor entry; Charge any fee due te Depostt Account Nox 16-0631,
`
`eu
`
`

`

`Unitep States Parent aNp TRADEMARK OFFICE
`
`
`
`
`
`APPLICATION
`NUMBER
`14/195,435
`
`FILING or
`371(¢) DATE
`03/03/2014
`
`
`
`GRP ART
`UNIT
`3767
`
`UNITED STATES DEPARTMENT OF COMMERCE
`Unicerd Scntes Patent and Trademark Office
`Address COMMISSIONER FOR PATE,
`PO Hoy 1480
`Aelia. Virginta 214-140
`jad pte
`WR Cope y
`
`
`
`FEL FEE REC'D
`ATTY DOCKET.NO
`
`1710
`2005. 86USREI6
`
`TOT CLAIMSTIND CLAIMS
`23
`]
`CONFIRMATION NO. 9278
`UPDATED FILING RECEIPT
`ee
`
`24113
`PATTERSON THUENTE PEDERSEN, P.A.
`4800IOSCENTER
`
`MINNEAPOLIS, MN 55402-2100
`
`Date Mailed: 04/02/2014
`
`Receipt is acknowledged of this reissue patent application. The application will be taken up for examination in
`due course. Applicant will be notified as to the results of the examination. Any correspondence concerning the
`application mustinclude the following identification information: the U.S. APPLICATION NUMBER, FILING DATE,
`NAME OF APPLICANT, and TITLE OF INVENTION. Fees transmitted by check or draft are subject to collection.
`Please verify the accuracy of the data presented on this receipt. If an error is noted on this Filing Receipt, please
`submit a written requestfor a Filing Receipt Correction. Please provide a copyofthis Filing Receipt with the
`changesnoted thereon. If you received a “Notice to File Missing Parts" for this application, please submit
`any corrections to this Filing Receipt with your reply to the Notice. When the USPTO processesthe reply
`to the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections
`
`Inventor(s)
`
`Howard C. Root, Tonka Bay, MN;
`Gregg Sutton, Plymouth, MN;
`
`seneywn anesve, MN;
`‘
`¥. —
`Which isaDIV of 12/824.734 0628/2010 PAT 8142413
`Vascular Solutions, Inc., Minneapolis, MN
`Which is a DIV of 11/416,629 05/03/2006 PAT 8048032
`Powerof Attorney: The patentpractitioners associated with Customer Number 24113
`
`This application is a CON of 14/070,161_11/01/2013 PAT RE45380
`Which is a REI of 13/359,059 01/26/2012 PAT 8292850
`
`
`
`Applicant(s)
`
`Domestic Priority data as claimed by applicant
`
`This application is a REI of 13/359,059 01/26/2012 PAT 8292850
`
`
`
`Osrrairie'aDIVof TOSI,T34USTERTIOTOPATBTS2A1S
`hichis-a-
`REtoH-43/359-
`webct ise Ott of T2824, 734 BGH2B2048 PATS faaao Which is a DIV of 11/416,629 05/03/2006 PAT 8048032
`
`whieh is-e-BACeHHHT446-629$510SABERAFBBB
`
`Foreign Applications for whichpriority is claimed (You may beeligible to benefit from the Patent Prosecution
`Highway program at the USPTO. Please see http://www.uspto.gov for more information.) - None.
`Foreign application information must be provided in an Application Data Sheetin orderto constitute a claim to
`foreign priority. See 37 CFR 1.55 and 1.76.
`
`If Required, Foreign Filing License Granted: 03/19/2014
`The country code and numberof yourpriority application, to be usedforfiling abroadWRCfhetpris Convention,
`is US 14/195,435
`pOCKETING
`Projected Publication Date: None, application is noteligible for pre-grant publication
`Non-Publication Request: No
`7
`page 1 of 3
`APR T- roid
`PATTERSON THERE
`pene ci of}
`Noskotes Mowles
`
`

`

`Early Publication Request: No
`™ SMALL ENTITY ™
`Title
`
`COAXIAL GUIDE CATHETER FOR INTERVENTIONAL CARDIOLOGY PROCEDURES
`Preliminary Class
`
`604
`
`Statement under 37 CFR 1.55 or1.78 for AIA (First Inventor to File) Transition Applications: No
`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughout theterritory of the United States and have-no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application underthe Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the sameinvention in membercountries, but does not result ina grant of “an international
`patent” and does not eliminate the needof applicantsto file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country hasits own patent law, and a person desiring a patent in a particular country must make an
`application for patentin that country in accordancewith its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advised that in the case of inventions madein the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a U.S. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidance as to the status of applicant's license for foreignfiling.
`
`Applicants may wish to consult the USPTO booklet, "General |nformation Concerning Patents” (specifically, the
`section entitled “Treaties and Foreign Patents") for more information on timeframes and deadlines forfiling foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, orit
`can be viewed on the USPTO website at http:/Awww.uspto.gov/web/offices/pac/doc/general/index.html.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, http:/Avww.stopfakes.gov. Part of a Department of Commerceinitiative,
`this website includesself-help "toolkits" giving innovators guidance on howto protect intellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues, applicants may
`call the U.S. Government hotline at 1-866-999-HALT (1-866-999-4258).
`
`page 2 of 3
`
`

`

`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`GRANTED
`
`The applicant has been granted a license under 35 U.S.C. 184, if the phrase “IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED"followed by a date appears onthis form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whetheror not a license may be required as
`set forth in 37 CFR 5.15. The scope andlimitations ofthis license are set forth in 37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The licenseis subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR §.13 or 5.14.
`
`This licenseis to be retained bythe licensee and maybe usedat anytime on orafter the effective date thereof unless
`itis revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53(d). This
`license is not retroactive.
`
`The grantofa license doesnot in any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Governmentcontractor the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControl, Department of
`Treasury (31 CFR Parts 500+) and the Departmentof Energy.
`
`NOT GRANTED
`
`No license under 35 U.S.C. 184 has been granted at this time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED” DOES NOTappear onthis form. Applicant maystill petition for a license under 37 CFR 5.12,
`if a license is desired before the expiration of 6 months from thefiling date of the application. If 6 months has lapsed
`from thefiling date of this application and the licensee has not received anyindication of a secrecy order under 35
`U.S.C. 181, the licensee may foreignfile the application pursuant to 37 CFR 5.15(b).
`
`SelectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business investment, innovation, and commercialization of new technologies. The U.S. offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation works to
`promote and facilitate business investment. SelectUSA provides information assistance to the international investor
`community; serves as an ombudsman for existing and potential investors; advocates on behalf of U.S. cities, states,
`and regions competing for global investment; and counsels U.S. economic developmentorganizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business, visit http:/Avww.SelectUSA.gov orcall
`+1-202-482-6800.
`
`page 3 of 3
`
`